166 related articles for article (PubMed ID: 27507082)
1. Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer.
Vannucci L; Parenti G; Simontacchi G; Rastrelli G; Giuliani C; Ognibene A; Peri A
J Endocrinol Invest; 2017 Jan; 40(1):49-54. PubMed ID: 27507082
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
[TBL] [Abstract][Full Text] [Related]
3. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
[TBL] [Abstract][Full Text] [Related]
4. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.
Kim J; Cho SG; Kang SR; Kwon SY; Cho DH; Cho JS; Song HC
Medicine (Baltimore); 2017 Feb; 96(5):e6004. PubMed ID: 28151897
[TBL] [Abstract][Full Text] [Related]
5. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Serhal DI; Nasrallah MP; Arafah BM
J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive ¹³¹I Ablation for Differentiated Thyroid Cancer: Single Institution Experience.
Dayrit JC; Cunanan EC; Kho SA
Endocrinol Metab (Seoul); 2016 Sep; 31(3):410-415. PubMed ID: 27546873
[TBL] [Abstract][Full Text] [Related]
7. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A; Claudio Traino A; Boni G; Grosso M; Lazzeri P; Colato C; Davì MV; Francia G; Lazzeri M; Mariani G; Ferdeghini M
Nucl Med Commun; 2007 Mar; 28(3):215-23. PubMed ID: 17264781
[TBL] [Abstract][Full Text] [Related]
8. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
[TBL] [Abstract][Full Text] [Related]
9. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism.
Baajafer FS; Hammami MM; Mohamed GE
J Endocrinol Invest; 1999 Jan; 22(1):35-9. PubMed ID: 10090135
[TBL] [Abstract][Full Text] [Related]
11. Severe hyponatremia in association with I(131) therapy in a patient with metastatic thyroid cancer.
Nozu T; Yoshida Y; Ohira M; Okumura T
Intern Med; 2011; 50(19):2169-74. PubMed ID: 21963736
[TBL] [Abstract][Full Text] [Related]
12. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
[TBL] [Abstract][Full Text] [Related]
13. Low iodine diet in differentiated thyroid cancer: a review.
Li JH; He ZH; Bansal V; Hennessey JV
Clin Endocrinol (Oxf); 2016 Jan; 84(1):3-12. PubMed ID: 26118628
[TBL] [Abstract][Full Text] [Related]
14. The relationships between thyroid functions of short-term rapid hypothyroidism and blood lipid levels in post-thyroidectomy patients of differentiated thyroid cancer.
Yao J; Zhao J; Liu J; Jiang S; Guo S; Xu L; Zhang X; Sheng Q; Wang K; Liao L; Dong J
Front Endocrinol (Lausanne); 2023; 14():1114344. PubMed ID: 37181036
[TBL] [Abstract][Full Text] [Related]
15. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract][Full Text] [Related]
16. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
18. Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a clinical algorithm.
Johner A; Griffith OL; Walker B; Wood L; Piper H; Wilkins G; Baliski C; Jones SJ; Wiseman SM
Ann Surg Oncol; 2011 Sep; 18(9):2548-54. PubMed ID: 21547704
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the incidence and influencing factors of hyponatremia before
Cao JJ; Yun CH; Xiao J; Liu Y; Wei W; Zhang W
World J Clin Cases; 2021 Dec; 9(36):11173-11182. PubMed ID: 35071548
[TBL] [Abstract][Full Text] [Related]
20. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
